^○Naoko Hosono¹, Takahiro Yamauchi¹, Sunggi Chi², Seiichiro Katagiri³, Akihiko Gotoh³, Motoki Eguchi⁴, Takanobu Morishita⁴, Reiki Ogasawara⁵, Takeshi Kondo⁵, Masamitsu Yanada⁶, Kazuhito Yamamoto⁶, Tsutomu Kobayashi⁷, Junya Kuroda⁷, Kensuke Usuki⁸, Yoshikazu Utsu⁹, Nobuyuki Aotsuka⁹, Makoto Yoshimitsu¹⁰, Kenji Ishitsuka¹⁰, Takaaki Ono¹¹, Yosuke Minami² (1.Department of Hematology and Oncology, University of Fukui, 2.Dept. of Hematology, National Cancer Center Hospital East, 3.Dept. of Hematology, Tokyo Medical University Hospital, 4.Div. Hematology, Japanese Red Cross Aichi Medical Center Nagoya Daiichi Hospital, 5.Blood Disorders Center, Aiiku Hospital, 6.Dept. of Hematology/Cell Therapy, Aichi Cancer Center, 7.Div. of Hematology/Oncology, Kyoto Prefectural University of Medicine, 8.Dept. of Hematology, NTT Medical Center Tokyo, 9.Div. of Hematology, Japanese Red Cross Narita Hospital, 10.Dept. of Hematology, Kagoshima University Hospital, 11.Dept. of Hematology, Hamamatsu University Hospital)

^○Ryan C. Lynch¹, Abraham Avigdor^2,3, Matthew S. Mckinney⁴, Shankara Paneesha⁵, BjÖRn E. Wahlin⁶, John S. Hrom⁷, David Cunningham⁸, Nicholas Morley⁹, Miguel Canales¹⁰, Mariana Bastos-Oreiro¹¹, David Belada¹², Liliana Devizzi¹³, Fred Zheng¹⁴, Douglas J. Demarini¹⁴, Wei Jiang¹⁴, Marek Trněný¹⁵ (1.Seattle Cancer Care Alliance, University of Washington School of Medicine, Fred Hutchinson Cancer Research Center, 2.Sackler Faculty of Medicine, Tel Aviv University, 3.Institute of Hematology, Sheba Medical Center, 4.Duke Cancer Institute, 5.Department of Haematology & Stem Cell Transplantation, Birmingham Heartlands Hospital, 6.Karolinska Institutet, Department of Medicine, Huddinge, and Karolinska University Hospital, Unit for Hematology, 7.Forrest General Hospital and Hattiesburg Clinic, 8.Royal Marsden Hospital, NHS Foundation Trust, 9.Sheffield Teaching Hospital NHS Foundation Trust, 10.Hospital Universitario La Paz, 11.Hospital General Universitario Gregorio Marañón (IiSGM), 12.4th Department of Internal Medicine – Hematology, Charles University, Hospital and Faculty of Medicine, 13.Fondazione IRCCS Istituto Nazionale dei Tumori di Milano, 14.Incyte Corporation, 15.First Department of Medicine – Hematology, Charles University General Hospital)

^○David Belada¹, Jacob H. Christensen², Kristina Drott³, Sylvia Snauwaert⁴, Joshua Brody⁵, Mayur Narkhede⁶, Fritz Offner⁷, Brian Elliott⁸, Tracy Liu⁸, Mariana Cota Stirner⁹, Aqeel Abbas⁸, Lorenzo Falchi¹⁰, Michael Roost Clausen¹¹ (1.4th Department of Internal Medicine-Hematology, University Hospital and Faculty of Medicine, Hradec Kralove, Czech Republic, 2.Odense University Hospital, Odense, Denmark, 3.Skane University Hospital, Scania, Sweden, 4.Department of Hematology, AZ Sint-Jan Hospital, Bruges, Belgium, 5.Icahn School of Medicine at Mount Sinai, New York, NY, USA, 6.O’Neal Comprehensive Cancer Center at UAB, Birmingham, AL, USA, 7.Universitair Ziekenhuis Gent, Ghent, Belgium, 8.Genmab, Princeton, NJ, USA, 9.AbbVie, North Chicago, IL, USA, 10.Lymphoma Service, Memorial Sloan Kettering Cancer Center, New York, NY, USA, 11.Vejle Hospital, Vejle, Denmark)

^○Anik R Patel¹, M Lia Palomba², Paola Ghione^2,3, Kevin Deighton⁴, Caron A Jacobson⁵, Myrna Nahas³, Scott Jung³, Anthony Hatswell⁴, Steve Kanters⁶, Eve Limbrick-Oldfield⁶, Sally W Wade⁷, Julia Thornton Snider³, Sattva S Neelapu⁸, Maria Teresa Riberio⁹, John Gribben¹⁰, John Radford¹¹, Sabela Bobillo¹², Herve Ghesquieres¹³ (1.Kite, a Gilead Company, Santa Monica, CA, USA, 2.Memorial Sloan Kettering Cancer Center, New York, NY, USA, 3.Roswell Park Comprehensive Cancer Center, Buffalo, NY, USA, 4.Delta Hat, Nottingham, UK, 5.Dana-Farber Cancer Institute, Boston, MA, USA, 6.RainCity Analytics, Vancouver, BC, Canada, 7.Wade Outcomes Research and Consulting, Salt Lake City, UT, USA, 8.The University of Texas MD Anderson Cancer Center, Houston, TX, USA, 9.Portuguese Oncology Institute of Porto, Porto, Portugal, 10.Cancer Research UK Barts Centre, London, UK, 11.The Christie NHS Foundation Trust and University of Manchester, Manchester, UK, 12.Vall D’Hebron Institute of Oncology, Barcelona, Spain, 13.Centre Hospitalier Lyon Sud, Lyon, France)

^○Sattva S. Neelapu¹, Julio C. Chavez², Alison R. Sehgal³, Narendranath Epperla⁴, Matthew Ulrickson⁵, Emmanuel Bachy⁶, Pashna N. Munshi⁷, Carla Casulo⁸, David G. Maloney⁹, Sven De Vos¹⁰, Ran Reshef¹¹, Lori A. Leslie¹², Olalekan O. Oluwole¹³, Ibrahim Yakoub-Agha¹⁴, Rashmi Khanal¹⁵, Joseph Rosenblatt¹⁶, Marika Sherman¹⁷, Jinghu Dong¹⁷, Alessandro Giovanetti¹⁷, Yin Yang¹⁷, Christine Lui¹⁷, Zahid Bashir¹⁷, A. Scott Jung¹⁷, Caron A. Jacobson¹⁸ (1.The University of Texas MD Anderson Cancer Center, 2.University of South Florida H. Lee Moffitt Cancer Center and Research Institute, Tampa, FL, USA, 3.UPMC Hillman Cancer Center, Pittsburgh, PA, USA, 4.The Ohio State University Comprehensive Cancer Center, Columbus, OH, USA, 5.Banner MD Anderson Cancer Center, Gilbert, AZ, USA, 6.Centre Hospitalier Lyon Sud, Pierre-Bénite, France, 7.Georgetown Lombardi Comprehensive Cancer Center, Washington, DC, USA, 8.University of Rochester Medical Center - James P. Wilmot Cancer Center, Rochester, NY, USA, 9.Fred Hutchinson Cancer Research Center, Seattle, WA, USA, 10.Ronald Reagan University of California Los Angeles Medical Center, Santa Monica, CA, USA, 11.Columbia University Herbert Irving Comprehensive Cancer Center, New York City, NY, USA, 12.John Theurer Cancer Center, Hackensack, NJ, USA, 13.Vanderbilt University Medical Center, Nashville, TN, USA, 14.CHU de Lille, Univ Lille, INSERM U1286, Infinite, 59000 Lille, France, 15.Fox Chase Cancer Center, Philadelphia, PA, USA, 16.University of Miami Sylvester Comprehensive Cancer Center, Miami, FL, USA, 17.Kite, a Gilead Company, Santa Monica, CA, USA, 18.Dana-Farber Cancer Institute, Boston, MA, USA)